Herantis Pharma Oyj (HRTIS) — Strategic Asset Allocation Index

Latest as of June 2022: 0.0%

Herantis Pharma Oyj (HRTIS) has a Strategic Asset Allocation Index of 0.0% as of June 2022. Strategic assets (PP&E of €0.00 plus long-term investments of €-) total €0.00, measured against net assets of €1.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See HRTIS equity to assets ratio to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

€0.00
PP&E + LT Investments

PP&E

€0.00
EUR

Net Assets

€1.92 Million
EUR

Herantis Pharma Oyj Strategic Asset Allocation Index (2013–2021)

This chart shows how Herantis Pharma Oyj's Strategic Asset Allocation Index has evolved across 8 annual periods from 2013 to 2021. As of June 2022, the index stands at 0.0%, representing strategic assets of €0.00 against net assets of €1.92 Million EUR. For live market cap and overall valuation, see how much is Herantis Pharma Oyj worth.

Annual Strategic Asset Allocation Index for Herantis Pharma Oyj (2013–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for Herantis Pharma Oyj from 2013 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See HRTIS net asset value for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2021 0.0% €0.00 €0.00 €- €554.30K ▲ +0.0 pp
2020 0.0% €0.00 €0.00 €- €7.59 Million ▼ -0.2 pp
2019 0.2% €3.69K €3.69K €- €1.85 Million ▲ +0.0 pp
2017 0.2% €7.72K €6.56K €1.16K €4.09 Million ▼ -0.4 pp
2016 0.6% €9.91K €8.75K €1.16K €1.57 Million ▲ +0.6 pp
2015 0.0% €2.45K €1.29K €1.16K €6.00 Million ▲ +0.0 pp
2014 0.0% €3.16K €2.00K €1.16K €21.72 Million ▼ -1.7 pp
2013 1.7% €2.00K €2.00K €- €120.00K
pp = percentage points